Jieya Shao, Ph.D.
Affiliations: | 2002 | Oklahoma State University, Stillwater, OK, United States |
Area:
Biochemistry, Molecular BiologyGoogle:
"Jieya Shao"Parents
Sign in to add mentor| Robert L. Matts | grad student | 2002 | Oklahoma State University | |
| (Characterization of the molecular chaperone Hsp90 cohorts, p50cdc37 and protein phosphatase 5, and their differential regualtion of the biogenesis of the heme-regulated eIF2alpha kinase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang F, Zhu C, Cai S, et al. (2021) Ser Phosphorylation Inhibits Actin-Binding of Profilin-1 and Its Apoptosis-Sensitizing Activity. Frontiers in Cell and Developmental Biology. 9: 692269 |
| Zhu C, Rogers A, Asleh K, et al. (2020) Phospho-Ser-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer. Cell Reports. 31: 107745 |
| Lei JT, Shao J, Zhang J, et al. (2018) Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Cell Reports. 24: 1434-1444.e7 |
| Gates LA, Gu G, Chen Y, et al. (2018) Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets. Oncogene |
| Lei J, Shao J, Zhang J, et al. (2018) Abstract PD8-03: ESR1 gene fusions drive endocrine therapy resistance and metastasis in breast cancer Cancer Research. 78 |
| Lei J, Shao J, Zhang J, et al. (2017) Abstract PD2-03: Recurrent functionally diverse in-frameESR1gene fusions drive endocrine resistance in breast cancer Cancer Research. 77 |
| Wardell SE, Ellis MJ, Alley HM, et al. (2015) Efficacy of SERD/SERM Hybrid-CDK4/6 inhibitor combinations in models of endocrine therapy resistant breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Diamond MI, Cai S, Boudreau A, et al. (2015) Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1. The Journal of Biological Chemistry. 290: 9075-86 |
| Shao J, Zhang J, Crowder RJ, et al. (2015) Abstract PD6-4: ESR1 gene fusions implicated in endocrine therapy resistance of ER+ breast cancer Cancer Research. 75 |
| Udan-Johns M, Bengoechea R, Bell S, et al. (2014) Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Human Molecular Genetics. 23: 157-70 |